Bank of Nova Scotia held its position in shares of Imperva Inc (NYSE:IMPV) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 175,000 shares of the software maker’s stock at the close of the second quarter. Bank of Nova Scotia owned approximately 0.52% of Imperva worth $8,374,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. ETF Managers Group LLC purchased a new position in shares of Imperva in the 2nd quarter worth about $41,888,000. Clearbridge Investments LLC raised its holdings in shares of Imperva by 47.0% in the 1st quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock worth $51,826,000 after purchasing an additional 403,809 shares during the period. BlackRock Inc. raised its holdings in shares of Imperva by 11.3% in the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after purchasing an additional 215,170 shares during the period. Eagle Asset Management Inc. raised its holdings in shares of Imperva by 17.7% in the 2nd quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after purchasing an additional 192,625 shares during the period. Finally, Quantitative Investment Management LLC purchased a new position in shares of Imperva in the 2nd quarter worth about $8,546,000. Hedge funds and other institutional investors own 92.72% of the company’s stock.
IMPV has been the topic of a number of research reports. ValuEngine downgraded Imperva from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Monness Crespi & Hardt raised their price objective on Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Evercore ISI set a $56.00 price objective on Imperva and gave the stock a “buy” rating in a report on Friday, July 28th. Stephens restated an “overweight” rating and issued a $61.00 price objective (up from $53.00) on shares of Imperva in a report on Thursday, July 13th. Finally, Stifel Nicolaus restated a “hold” rating and issued a $47.00 price objective on shares of Imperva in a report on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $52.34.
In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the sale, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 2.20% of the stock is owned by insiders.
Shares of Imperva Inc (NYSE:IMPV) traded up 0.23% during midday trading on Friday, hitting $43.60. The company had a trading volume of 274,752 shares. The firm’s market cap is $1.47 billion. Imperva Inc has a one year low of $34.40 and a one year high of $52.40. The company’s 50 day moving average is $44.05 and its 200 day moving average is $45.83.
Imperva (NYSE:IMPV) last announced its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The company had revenue of $74.44 million during the quarter, compared to analyst estimates of $74.30 million. During the same period in the prior year, the firm earned ($0.23) EPS. Imperva’s quarterly revenue was up 28.6% on a year-over-year basis. Equities analysts forecast that Imperva Inc will post $0.81 earnings per share for the current fiscal year.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NYSE:IMPV).